Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)

Clinical trial NCT03088293 · WITHDRAWN

Trial details

NCT number: NCT03088293
Sponsor: Hospices Civils de Lyon
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Refractory Scleritis

Start date: 2020-06-11
Primary completion: 2023-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.